Academic unit: Millennium Institute on Immunology and Immunotherapy, MIII
Descubre los avances pioneros en inmunoterapia para el tratamiento de enfermedades en el IMII.
Descubre más aquí: IMII

Chilean RSV Vaccine to Begin Clinical Trials in Europe: Who Will Benefit?
The European Medicines Agency has approved a phase 2 clinical trial for the Respiratory Syncytial Virus (RSV) vaccine, developed by Chilean researchers led by…

Dr. Alexis Kalergis Honored as One of the World’s 50 Most Inspirational Scientists
Dr. Alexis Kalergis, Director of the Millennium Institute of Immunology and Immunotherapy (MIII) and Full Professor in the Faculties of Biological Sciences and…

Researchers from Beijing’s Tsinghua University Visit UC Chile to Explore Areas of Scientific Collaboration
The visit by a delegation of distinguished researchers from Tsinghua University—a leading university in China and Asia—aims to foster joint initiatives and…